Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-19-052713

Options or other derivatives

  • President and CSO acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Suri Anish · President and CSO

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-10-03 Grant or award : show line 1 in the form Stock Option (right to buy) +400,000 $7.53 $3,012,000 400,000 D
2019-10-03 Grant or award : show line 2 in the form Restricted Stock Units +100,000 0 D
Loading xslF345X03/doc4.xml…